250 related articles for article (PubMed ID: 9390567)
1. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
[TBL] [Abstract][Full Text] [Related]
2. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
[TBL] [Abstract][Full Text] [Related]
3. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of methods for collection and measurement of cytokines and immunoglobulins in cervical and vaginal secretions of HIV and HPV infected women.
Snowhite IV; Jones WE; Dumestre J; Dunlap K; Braly PS; Hagensee ME
J Immunol Methods; 2002 May; 263(1-2):85-95. PubMed ID: 12009206
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-nucleoside reverse transcriptase inhibitors on cytokine, chemokine, and immunoglobulin profiles in serum and genital secretions of HIV-infected women.
Sachdeva RK; Wanchu A; Bagga R; Malla N; Sharma M
J Interferon Cytokine Res; 2010 May; 30(5):299-310. PubMed ID: 20187769
[TBL] [Abstract][Full Text] [Related]
6. Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.
Mestecky J; Wright PF; Lopalco L; Staats HF; Kozlowski PA; Moldoveanu Z; Alexander RC; Kulhavy R; Pastori C; Maboko L; Riedner G; Zhu Y; Wrinn T; Hoelscher M
AIDS Res Hum Retroviruses; 2011 May; 27(5):469-86. PubMed ID: 21091128
[TBL] [Abstract][Full Text] [Related]
7. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
[TBL] [Abstract][Full Text] [Related]
8. Genital inflammation and the risk of HIV acquisition in women.
Masson L; Passmore JA; Liebenberg LJ; Werner L; Baxter C; Arnold KB; Williamson C; Little F; Mansoor LE; Naranbhai V; Lauffenburger DA; Ronacher K; Walzl G; Garrett NJ; Williams BL; Couto-Rodriguez M; Hornig M; Lipkin WI; Grobler A; Abdool Karim Q; Abdool Karim SS
Clin Infect Dis; 2015 Jul; 61(2):260-9. PubMed ID: 25900168
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
Haimovici F; Mayer KH; Anderson DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
[TBL] [Abstract][Full Text] [Related]
11. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
[TBL] [Abstract][Full Text] [Related]
12. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation.
Ghanem KG; Shah N; Klein RS; Mayer KH; Sobel JD; Warren DL; Jamieson DJ; Duerr AC; Rompalo AM;
J Infect Dis; 2005 Feb; 191(3):358-66. PubMed ID: 15633094
[TBL] [Abstract][Full Text] [Related]
13. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.
Kaul R; Trabattoni D; Bwayo JJ; Arienti D; Zagliani A; Mwangi FM; Kariuki C; Ngugi EN; MacDonald KS; Ball TB; Clerici M; Plummer FA
AIDS; 1999 Jan; 13(1):23-9. PubMed ID: 10207541
[TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
[TBL] [Abstract][Full Text] [Related]
15. Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood.
Haddad LB; Swaims-Kohlmeier A; Mehta CC; Haaland RE; Brown NL; Sheth AN; Chien H; Titanji K; Achilles SL; Lupo D; Hart CE; Ofotokun I
PLoS One; 2020; 15(3):e0230473. PubMed ID: 32214321
[TBL] [Abstract][Full Text] [Related]
16. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.
Al-Harthi L; Kovacs A; Coombs RW; Reichelderfer PS; Wright DJ; Cohen MH; Cohn J; Cu-Uvin S; Watts H; Lewis S; Beckner S; Landay A;
AIDS; 2001 Aug; 15(12):1535-43. PubMed ID: 11504986
[TBL] [Abstract][Full Text] [Related]
17. Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.
Herold BC; Keller MJ; Shi Q; Hoover DR; Carpenter CA; Huber A; Parikh UM; Agnew KJ; Minkoff H; Colie C; Nowicki MJ; DʼSouza G; Watts DH; Anastos K
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):485-93. PubMed ID: 23591635
[TBL] [Abstract][Full Text] [Related]
18. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
[TBL] [Abstract][Full Text] [Related]
19. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
Nowicki MJ; Laskus T; Nikolopoulou G; Radkowski M; Wilkinson J; Du WB; Rakela J; Kovacs A
J Infect Dis; 2005 Nov; 192(9):1557-65. PubMed ID: 16206070
[TBL] [Abstract][Full Text] [Related]
20. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments.
Al-Harthi L; Wright DJ; Anderson D; Cohen M; Matity Ahu D; Cohn J; Cu-Unvin S; Burns D; Reichelderfer P; Lewis S; Beckner S; Kovacs A; Landay A
J Interferon Cytokine Res; 2000 Aug; 20(8):719-24. PubMed ID: 10954915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
